RUA Life Sciences's market cap is currently ―. The company's EPS TTM is p-0.084; its P/E ratio is -1.33; RUA Life Sciences is scheduled to report earnings on July 17, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Mar 22	Sep 21	Mar 21	Sep 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 2.51M	£ 2.96M	£ 4.76M	£ 6.29M	£ 1.01M
Total Assets	£ 6.60M	£ 7.63M	£ 8.88M	£ 10.15M	£ 4.04M
Total Debt	£ 454.00K	£ 344.00K	£ 378.00K	£ 410.00K	£ 308.00K
Net Debt	£ -2.06M	£ -2.62M	£ -4.38M	£ -5.88M	£ -701.00K
Total Liabilities	£ 1.11M	£ 1.04M	£ 1.62M	£ 1.65M	£ 1.30M
Stockholders Equity	£ 5.49M	£ 6.58M	£ 7.26M	£ 8.51M	£ 2.75M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

RUA Life Sciences Earnings and Revenue History

Income Statement >

RUA Life Sciences Debt to Assets

Balance Sheet >

RUA Life Sciences Cash Flow

Cash Flow >

RUA Life Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing